Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anna Mizutani
RK-287107, a Potent and Specific Tankyrase Inhibitor, Blocks Colorectal Cancer Cell Growth in a Preclinical Model
Cancer Science
Cancer Research
Medicine
Oncology
mTOR Signaling Mediates Resistance to Tankyrase Inhibitors in WNT-Driven Colorectal Cancer
Oncotarget
Oncology
Related publications
A Small-Molecule E2F Inhibitor Blocks Growth in a Melanoma Culture Model
Cancer Research
Cancer Research
Oncology
ZD1839 (‘Iressa’), a Specific Oral Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor, Potentiates Radiotherapy in a Human Colorectal Cancer Xenograft Model
British Journal of Cancer
Cancer Research
Oncology
Preclinical Characterization of Anlotinib, a Highly Potent and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitor
Cancer Science
Cancer Research
Medicine
Oncology
Mitoxantrone Targets Human Ubiquitin-Specific Peptidase 11 (USP11) and Is a Potent Inhibitor of Pancreatic Cancer Cell Survival
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-overexpressing Preclinical Cancer Models
International Journal of Cancer
Cancer Research
Oncology
Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo
Cellular Physiology and Biochemistry
Physiology
Screen-Identified Selective Inhibitor of Lysine Demethylase 5A Blocks Cancer Cell Growth and Drug Resistance
Oncotarget
Oncology
Multiple Target-Specific Molecular Imaging Agents Detect Liver Cancer in a Preclinical Model
Current Molecular Medicine
Biochemistry
Medicine
Molecular Medicine
Molecular Biology
Preclinical Anti-Arthritic Study and Pharmacokinetic Properties of a Potent Histone Deacetylase Inhibitor MPT0G009
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
